AGR2 and cancer: After PSA normalization, a significant difference between the cancer and non-cancer urine was observed for the marker peptides [except for LPQTLSR of AGR2, VTSLTACLVDQSLR of CD90 and MVIITTK of CXL14] with P = 0.015-0.035 (Table 2 and Figure 3).